Skip to main content

Sector research & intelligence

Research catalogue

Premium investor briefs and competitive landscapes with named forward calls, across SUDEVCO's two lenses — Bioindustry & Bio-based Economy and Health & Nutrition. A small catalogue, carefully maintained, written from inside the industry.

Available

Investor Brief Health & Nutrition

Human Milk Oligosaccharides

Investor Brief

A 28-page sector note on Human Milk Oligosaccharides at the inflection point: a Chinese cost cohort now at near-parity with Western mature plants, the manufacturing-IP staircase running 2027 to 2035, and value migrating off the flagship 2'-FL into multi-HMO blends. Written from inside the industry, with a named, dated, falsifiable forward call on where the durable Western returns live..

28 pages · Data as of 2026-05-01 View brief →
Landscape Report Health & Nutrition

Human Milk Oligosaccharides

Competitive & Commercial Landscape

The definitive map of the HMO competitive and commercial landscape: twelve chapters and six appendices, 38+ named exhibits and 100+ public-record citations. Supply read plant-by-plant, the cost stack built bottom-up, the IP cliff as a maintenance-fee schedule with named expiries through 2042, regulatory access named structure by jurisdiction by player, and health evidence graded trial-by-trial.

77 pages · Data as of 2026-05-25 View report →

Coverage

Two lenses, built out one sector at a time — what is published today, and what is on the research agenda.

  • Industrial Enzymes In progress · 2026-Q3
  • Precision Fermentation & Synthetic Biology In progress · 2026-Q3
  • Classic Fermentation Planned · 2027-Q1
  • Specialty Bio-Ingredients Published · 2 reports →
  • Pre/Pro/Postbiotics — Supplements In progress · 2026-Q4
  • Pre/Pro/Postbiotics — Skin Microbiome Planned · 2027-Q1